1. Home
  2. SGMT vs OCG Comparison

SGMT vs OCG Comparison

Compare SGMT & OCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • OCG
  • Stock Information
  • Founded
  • SGMT 2006
  • OCG 2018
  • Country
  • SGMT United States
  • OCG Hong Kong
  • Employees
  • SGMT N/A
  • OCG N/A
  • Industry
  • SGMT
  • OCG Other Consumer Services
  • Sector
  • SGMT
  • OCG Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • OCG Nasdaq
  • Market Cap
  • SGMT 71.2M
  • OCG 84.7M
  • IPO Year
  • SGMT 2023
  • OCG 2020
  • Fundamental
  • Price
  • SGMT $3.55
  • OCG $5.31
  • Analyst Decision
  • SGMT Strong Buy
  • OCG
  • Analyst Count
  • SGMT 6
  • OCG 0
  • Target Price
  • SGMT $25.67
  • OCG N/A
  • AVG Volume (30 Days)
  • SGMT 392.3K
  • OCG 36.6K
  • Earning Date
  • SGMT 05-08-2025
  • OCG 06-10-2025
  • Dividend Yield
  • SGMT N/A
  • OCG N/A
  • EPS Growth
  • SGMT N/A
  • OCG N/A
  • EPS
  • SGMT N/A
  • OCG N/A
  • Revenue
  • SGMT N/A
  • OCG $622,690.00
  • Revenue This Year
  • SGMT N/A
  • OCG N/A
  • Revenue Next Year
  • SGMT N/A
  • OCG N/A
  • P/E Ratio
  • SGMT N/A
  • OCG N/A
  • Revenue Growth
  • SGMT N/A
  • OCG N/A
  • 52 Week Low
  • SGMT $1.73
  • OCG $0.91
  • 52 Week High
  • SGMT $7.38
  • OCG $7.47
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 57.81
  • OCG 50.91
  • Support Level
  • SGMT $3.18
  • OCG $5.08
  • Resistance Level
  • SGMT $3.85
  • OCG $6.04
  • Average True Range (ATR)
  • SGMT 0.27
  • OCG 0.72
  • MACD
  • SGMT 0.01
  • OCG -0.16
  • Stochastic Oscillator
  • SGMT 61.04
  • OCG 14.29

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About OCG Oriental Culture Holding LTD

Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance service to customers in China and Hong Kong. It operates through one segment namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.

Share on Social Networks: